About Molecular Assemblies
Molecular Assemblies is a company based in San Diego (United States) founded in 2013. Molecular Assemblies has raised $78.48 million across 10 funding rounds from investors including ARE, Agilent and Wellfound. The company has 21 employees as of December 31, 2020. Molecular Assemblies offers products and services including Fully Enzymatic Synthesis (FES) and Long Oligos. Molecular Assemblies operates in a competitive market with competitors including Amyris, Syngenta, AskBio, Ginkgo Bioworks and Antheia, among others.
- Headquarter San Diego, United States
- Employees 21 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Molecular Assemblies, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$78.48 M (USD)
in 10 rounds
-
Latest Funding Round
$25.8 M (USD), Series B
Mar 15, 2022
-
Investors
ARE
& 16 more
-
Employee Count
21
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Molecular Assemblies
Molecular Assemblies offers a comprehensive portfolio of products and services, including Fully Enzymatic Synthesis (FES) and Long Oligos.
Technology for producing long, pure DNA oligos efficiently without purification needs.
High-purity DNA sequences for research and applications in various fields.
People of Molecular Assemblies
Unlock access to complete
Unlock access to complete
Funding Insights of Molecular Assemblies
Molecular Assemblies has successfully raised a total of $78.48M across 10 strategic funding rounds. The most recent funding activity was a Series B round of $25.8 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Molecular Assemblies
Molecular Assemblies has secured backing from 17 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include ARE, Agilent and Wellfound.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Locked | Locked | Locked | |
|
Early-stage investments are targeted by iSelect Fund in key sectors.
|
Locked | Locked | Locked | |
|
LYFE Capital is recognized as a premier healthcare investment platform.
|
Locked | Locked | Locked |
Investor details for Molecular Assemblies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Molecular Assemblies
Investment portfolio details for Molecular Assemblies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Molecular Assemblies
Detailed financials for Molecular Assemblies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Molecular Assemblies Comparisons
Peer comparison for Molecular Assemblies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Molecular Assemblies
Molecular Assemblies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Syngenta, AskBio, Ginkgo Bioworks and Antheia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of renewable products for industrial solutions
|
|
| Locked | Locked | Locked |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| Locked | Locked | Locked |
Gene and protein therapies are developed for treating various diseases.
|
|
| Locked | Locked | Locked |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Synthetic DNA is synthesized via a semiconductor-based platform.
|
Detailed competitors of Molecular Assemblies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Molecular Assemblies
Complete news archive for Molecular Assemblies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Molecular Assemblies
Molecular Assemblies was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Molecular Assemblies is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Molecular Assemblies is a funded company, having raised a total of $78.48M across 10 funding rounds to date.
As of Dec 31, 2020, the latest employee count at Molecular Assemblies is 21.
Molecular Assemblies was founded in 2013 and is based in San Diego, United States. Enzymatic methods for synthesizing long DNA molecules with high sequence specificity are developed by the company. These products support applications in synthetic biology, personalized medicine, and biocomputing. Operations focus on delivering reliable tools to researchers for downstream genetic engineering tasks.
Molecular Assemblies offers Fully Enzymatic Synthesis (FES) and Long Oligos.